american academy of cardiology glp 1 2025 ACC Scientific Statement on the Management Obesity in Adults With Heart Failure: A Report of the College of Glucagon-like peptide 1 receptor agonists:
Description
Compelling CVOT data: Ultimately, health systems attribute value to cardiovascular outcomes, not weight loss on its own
Purpose of Review This review explores the role of GLP-1 receptor agonists (GLP-1 RAs) in addressing metabolic dysfunction and neurodegeneration in Parkinsons disease (PD), focusing on body weight regulation and neuroprotection
GLP-1 Friendly Grocery List (US Letter PDF)
Medical director at Phoenix and Raven explains why brand-name Ozempic still leads despite Health Canada approvals
Lilly narrows gap with Novo Nordisk in GLP-1 market as Q2 2024 sales figures show strong growth, but Ozempic remains the GLP-1 king.
